General Information of DTT (ID: TTTWS2G)

DTT Name Human immunodeficiency virus Capsid p24 (HIV p24) DTT Info
Gene Name HIV p24

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lenacapavir DMW7TZV Human immunodeficiency virus-1 infection 1C62 Approved [1]
------------------------------------------------------------------------------------
4 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
F4co vaccine DM6UQNW Human immunodeficiency virus infection 1C62 Phase 2 [2]
Vacc-4x DMDAKZW Human immunodeficiency virus-1 infection 1C62 Phase 2 [3]
VH4004280 DMM5L3S Human immunodeficiency virus infection 1C62 Phase 1 [4]
VH4011499 DM1GSSM Human immunodeficiency virus infection 1C62 Phase 1 [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Gilead Sciences.
2 EP patent application no. 2621528, Vaccine.
3 Clinical pipeline report, company report or official report of Bionor Pharma.
4 Clinical pipeline report, company report or official report of ViiV Healthcare